Security key
G9845F208
LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share (LSBCF)
CUSIP: G9845F208
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Ordinary Shares, par value $0.0002 per share
- Total 13F shares
- 1,447,850
- Total 13F value
- $1,015,183
- Share change
- +1,059,246
- SEC-reported price per share
- $2.42
- Number of holders
- 9
- Value change
- +$69,432
- Number of buys
- 4
- Shares outstanding
- 41,218,298
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
9
Top holders
9
LSBCF full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
LakeShore Biopharma Co., Ltd. SEC filings
LakeShore Biopharma Co., Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP G9845F208
Recent filing periods:
Ownership snapshot
Top reported holders of LSBCF - LakeShore Biopharma Co., Ltd. - Ordinary Shares, par value $0.0002 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
6/6
Latest evidence
31 Dec 2024
13F
Lead comparable stake: 0.34%
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 0.34%.
6 of 6 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
0.34%
FMR LLC
0.28%
HHLR ADVISORS, LTD.
0.18%
SUPERSTRING CAPITAL MANAGEMENT LP
0.07%
BARCLAYS PLC
0.06%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 6 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
0.34%
|
$485,881
140,428 shares
|
— | 31 Dec 2024 |
| FMR LLC |
13F
Company
|
0.28%
|
$401,953
116,508 shares
|
— | 31 Dec 2024 |
| HHLR ADVISORS, LTD. |
13F
Company
|
0.18%
|
$259,368
75,179 shares
|
— | 31 Dec 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
Company
|
0.07%
|
$106,232
30,792 shares
|
— | 31 Dec 2024 |
| BARCLAYS PLC |
13F
Company
|
0.06%
|
$85,659
24,757 shares
|
— | 31 Dec 2024 |
| UBS Group AG |
13F
Company
|
0%
|
$3,252
940 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
9
Shares
1,447,850
Rows available
9
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q1 2025 holders
9
Holder diff
8
| Investor | Q3 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend